Allarity Therapeutics Announces Extraordinary Exercise Period for Warrants of Series ALLR TO 3 Set to August 30 – September 13, 2021
Press Release
Hørsholm, Denmark (August 26,2021) Allarity Therapeutics A/S (Allarity or the Company) today announces that an accelerated extraordinary and final exercise period for warrants of the ALLR TO 3 series (the TO 3 Warrants), which were issued…
